Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Cystic fibrosis Stories

2012-10-22 15:25:10

SAN DIEGO and CAMBRIDGE, Mass., Oct. 22, 2012 /PRNewswire/ -- Good Start Genetics®, a leading and innovative molecular diagnostics company offering the new gold standard for genetic disease carrier screening, announced today that it has launched an expanded menu of testing services. The announcement, made at this week's annual meeting of the American Society for Reproductive Medicine (ASRM), means that Good Start Genetics' screening service, GoodStart Select(TM), now offers...

2012-10-12 07:23:25

ABBOTT PARK, Ill., Oct. 12, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today the winners of the CFCareForward Thriving Undergraduate and Graduate Scholarship award. Mark Moening, a Virginia Beach, Va. resident, and Wesley McSparin, a native of Paducah, Ky., were unveiled as the 2012 Thriving Undergraduate and Graduate Scholarship recipients, respectively. In celebration of the 20(th) anniversary of the program, the total award is $20,000. Earlier this year, 40 undergraduate and...

2012-10-09 11:27:57

Conference Follows FDA Approval of Historic Drug to Treat Underlying Cause of CF - A Fatal Disease BETHESDA, Md., Oct. 9, 2012 /PRNewswire-USNewswire/ -- In the largest meeting of its kind, nearly 4,000 doctors, scientists and clinicians from diverse disciplines will meet in Orlando, Fla., Oct. 11 - 13, 2012, to present the latest advancements in cystic fibrosis research, care and drug development. Highlighted topics of the 26th annual North American Cystic Fibrosis Conference include:...

2012-10-08 11:24:04

RESEARCH TRIANGLE PARK, N.C., Oct. 8, 2012 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, announced today that the first patient has been enrolled and dosed in a phase II study evaluating the safety and tolerability of Alpha-1 HC aerosol in patients with cystic fibrosis. Cystic fibrosis is an inherited disease that causes progressive decline in lung function, including acute episodes of worsening respiratory symptoms and potentially fatal lung infections....

2012-10-08 07:23:37

BOULDER, Colo., Oct. 8, 2012 /PRNewswire/ -- N30 Pharmaceuticals, Inc. today announced the addition of Dr. Sherif Gabriel to its senior leadership team. Prior to joining N30 Pharma, Dr. Gabriel was on the faculty of the University of North Carolina Cystic Fibrosis Center, Director of the Cystic Fibrosis Correction Core of the Center, and Associate Professor in the Department of Pediatrics, Division of Pulmonology. Dr. Gabriel's career has revolved around the molecular regulation of ion and...

2012-10-02 10:28:21

NEW YORK, Oct. 2, 2012 /PRNewswire-iReach/ -- The Johns Hopkins University School of Medicine (JHUSOM), in collaboration with the Institute for Johns Hopkins Nursing (IJHN) and DKBmed, LLC, has announced the presentation of Ahead of the Curve: Early Intervention in Cystic Fibrosis, featuring the first-ever three-dimensional animation at any North American CME program. (www.aotc-early.org) The symposia stresses the importance of early initiation of treatment and identification of lung...

2012-09-18 23:02:29

Ongoing series of webinars featuring healthcare professionals and patients address the challenges faced by people with lung disease. PMD Healthcare manufactures Spiro PD, the world´s first truly personal spirometer. For more information, visit http://www.SpiroPD.com. Allentown, PA (PRWEB) September 18, 2012 PMD Healthcare is conducting a series of free webinars to help educate and empower people with lung diseases — asthma, chronic obstructive pulmonary disease (COPD),...

2012-09-11 02:28:40

MONMOUTH JUNCTION, N.J., Sept. 11, 2012 /PRNewswire/ -- Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing novel inhalation therapeutics for patients suffering from serious orphan lung diseases, today announced the appointment of Will Lewis as President and Chief Executive Officer, effective immediately. Mr. Lewis has also been appointed to the Company's Board of Directors. He succeeds Tim Whitten, who has resigned as President and Chief Executive Officer...

2012-09-05 14:23:33

EAST HANOVER, N.J., Sept. 5, 2012 /PRNewswire/ -- The Anti-Infective Drugs Advisory Committee (AIDAC) to the US Food and Drug Administration (FDA) today voted 13 to 1 that there was adequate evidence of efficacy and safety to support the use of tobramycin inhalation powder (TIP) for the management of cystic fibrosis (CF) patients whose lungs contain bacteria called Pseudomonas aeruginosa (Pa). Pa is the leading cause of loss of lung function in people with CF. TIP is intended for use in CF...

2012-08-29 23:03:43

William Clay, Chief Financial Officer for the Nashville parking management company Premier Parking has been recognized as one of Nashville´s Top 30 Under 30. Those selected by the Cystic Fibrosis Foundation are some of the most active and influential members of their local business community. Nashville, TN (PRWEB) August 28, 2012 For the past three years the Cystic Fibrosis Foundation (CFF) has been recognizing influential members of local business communities under the age of 30. In...


Latest Cystic fibrosis Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »